吉屋 匠平

Medicine and Dentistry

1. Adult 6%
2. Albumin 8%
3. Analysis 6%
4. Bleeding 5%
5. Cancer 5%
6. Cholangiocarcinoma 5%
7. Combination Therapy 5%
8. Common Hepatic Artery 7%
9. Donor 65%
10. Endoscopic Retrograde Cholangiopancreatography 5%
11. Graft Survival 9%
12. Hepatectomy 43%
13. Hepatic Portal Vein 5%
14. Hepatic Vein 11%
15. Hepatocellular Carcinoma 59%
16. Incidence 7%
17. Inpatient 22%
18. Interferon 6%
19. Liver 5%
20. Liver Transplantation 53%
21. Lymphocyte 9%
22. Malignant Neoplasm 5%
23. Multivariate Analysis 5%
24. Neoplasm 16%
25. Overall Survival 14%
26. Patient 100%
27. Platelet 8%
28. Portal Vein Thrombosis 7%
29. Predictor 5%
30. Prognosis 11%
31. Programmed Death 1 Ligand 1 7%
32. Recurrence Free Survival 9%
33. Recurrent Disease 9%
34. Sepsis 7%
35. Serum 5%
36. Stone 5%
37. Surgery 24%
38. Surgical Anastomosis 7%
39. Survival Rate 11%
40. Therapeutic Procedure 6%